PMDA — authorised 1 August 2019
- Marketing authorisation holder: OTSUKA PHARMACEUTICAL CO., LTD.
- Status: approved
PMDA authorised Revex on 1 August 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 1 August 2019.
OTSUKA PHARMACEUTICAL CO., LTD. holds the Japanese marketing authorisation.